Spred-1 negatively regulates allergen-induced airway eosinophilia and hyperresponsiveness

被引:96
作者
Inoue, H [1 ]
Kato, R
Fukuyama, S
Nonami, A
Taniguchi, KI
Matsunmoto, K
Nakano, T
Tsuda, M
Matsumura, M
Kubo, M
Ishikawa, F
Moon, BG
Takatsu, K
Nakanishi, Y
Yoshimura, A
机构
[1] Kyushu Univ, Higashi Ku, Res Inst Dis Chest, Grad Sch Med Sci, Fukuoka 8128582, Japan
[2] Kyushu Univ, Higashi Ku, Div Mol & Cellular Immunol, Med Inst Bioregulat, Fukuoka 8128582, Japan
[3] Kyushu Univ, Higashi Ku, Dept Internal Med 1, Fac Med, Fukuoka 8128582, Japan
[4] Inst Chem & Phys Res RIKEN, Lab Signal Network, RIKEN Res Ctr Allergy & Immunol, Yokohama Inst, Yokohama, Kanagawa 2300045, Japan
[5] Univ Tokyo, Dept Immunol, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan
关键词
D O I
10.1084/jem.20040616
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T helper 2 cytokines, including interleukin (IL)-4, IL-5, and IL-13, play a critical role in allergic asthma. These cytokines transmit signals through the Janus kinase/signal transducer and activator of transcription (STAT) and the Ras-extracellular signal-regulated kinase (ERK) signaling pathways. Although the suppressor of cytokine signaling (SOCS) family proteins have been shown to regulate the STAT pathway, the mechanism regulating the ERK pathway has not been clarified. The Sprouty-related Ena/VASP homology 1-domain-containing protein (Spred)-1 has recently been identified as a negative regulator of growth factor-mediated, Ras-dependent ERK activation. Here, using Spred-1-deficient mice, we demonstrated that Spred-1 negatively regulates allergen-induced airway eosinophilia and hyperresponsiveness, without affecting helper T cell differentiation. Biochemical assays indicate that Spred-1 suppresses IL-5-dependent cell proliferation and ERK activation. These data indicate that Spred-1 negatively controls eosinophil numbers and functions by modulating IL-5 signaling in allergic asthma.
引用
收藏
页码:73 / 82
页数:10
相关论文
共 57 条
[1]  
ADACHI T, 1998, AM J PHYSIOL, V375, pC623
[2]  
Busse William W., 2000, Journal of Allergy and Clinical Immunology, V106, P1033
[3]   Analysis of signal transduction pathways in human eosinophils activated by chemoattractants and the T-helper 2-derived cytokines interleukin-4 and interleukin-5 [J].
Coffer, PJ ;
Schweizer, RC ;
Dubois, GR ;
Maikoe, T ;
Lammers, JWJ ;
Koenderman, L .
BLOOD, 1998, 91 (07) :2547-2557
[4]   Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity [J].
Corry, DB ;
Folkesson, HG ;
Warnock, ML ;
Erle, DJ ;
Matthay, MA ;
WienerKronish, JP ;
Locksley, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (01) :109-117
[5]  
DEMONCHY JGR, 1985, AM REV RESPIR DIS, V131, P373
[6]   INTERLEUKIN-5 SYNTHESIS BY EOSINOPHILS - ASSOCIATION WITH GRANULES AND IMMUNOGLOBULIN-DEPENDENT SECRETION [J].
DUBUCQUOI, S ;
DESREUMAUX, P ;
JANIN, A ;
KLEIN, O ;
GOLDMAN, M ;
TAVERNIER, J ;
CAPRON, M ;
CAPRON, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (02) :703-708
[7]  
Dumont FJ, 1998, J IMMUNOL, V160, P2579
[8]   Activation of the extracellular signal-regulated kinase pathway is differentially required for TCR-stimulated production of six cytokines in primary T lymphocytes [J].
Egerton, M ;
Fitzpatrick, DR ;
Kelso, A .
INTERNATIONAL IMMUNOLOGY, 1998, 10 (02) :223-229
[9]   Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model [J].
Foster, PS ;
Hogan, SP ;
Ramsay, AJ ;
Matthaei, KI ;
Young, IG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (01) :195-201
[10]   Differential regulation of human eosinophil IL-3, IL-5, and GM-CSF receptor α-chain expression by cytokines:: IL-3, IL-5, and GM-CSF down-regulate IL-5 receptor α expression with loss of IL-5 responsiveness, but up-regulate IL-3 receptor a expression [J].
Gregory, B ;
Kirchem, A ;
Phipps, S ;
Gevaert, P ;
Pridgeon, C ;
Rankin, SM ;
Robinson, DS .
JOURNAL OF IMMUNOLOGY, 2003, 170 (11) :5359-5366